07 April 2024

Treating rUTIs: Immunomodulation or oestrogen therapy?

In the Thematic Session “Controversies on EAU Guidelines: Neurourology, paediatric urology and infections”, Co-Chair Prof. Gernot Bonkat (CH) presented and

07 April 2024

EAUTV: Prostate Cancer Screening at EAU24

07 April 2024

EAUTV: Surgical Complications at EAU24

07 April 2024

The one about the urologist who never has complications

ESU Chair Prof. Liatsikos (GR) has met the urologist who never has complications: “He comes in at 9:30, gets a

07 April 2024

PCa Game changers: Limited versus extended PLND?

On day three of EAU24, the newest data comparing limited versus extended pelvic lymph node dissection (ePLND) in prostate cancer

07 April 2024

Highlights from Day 2 at EAU24

See the highlights of EAU24’s day 2, including session reports on prostate cancer screening and live surgeries, PRIME and PROBASE

06 April 2024

YUORDay24: New technologies for surgeons?

Led by ESRU Chair Dr. Enrico Checcucci (IT) and YUO Chair Assoc. Prof. Juan Luis Vásquez (DK), the full day

06 April 2024

EAUTV: Stone Management at EAU24

06 April 2024

EAUTV: Future of Urology at EAU24

06 April 2024

EAU Live Surgery: Single-port system, livestreaming from Belgium and an overview

The live and semi-live surgeries, some of the EAU Congress’s pièces de résistance, commenced today and were led by the

06 April 2024

Game-changers: Guideline changes in screening and diagnosis for PCa?

On day two of EAU24, the game-changing session featured first time results, and discussion on three prostate cancer (PCa) screening

06 April 2024

Plenary Session takes on responsible AI and green urology

Will the surge of artificial intelligence (AI) and other technologies eventually cause the obsolescence of open surgery? Prof. Prokar Dasgupta

06 April 2024

Plenary Session on PCa: “Are we poised for screening?”

A common thread through the talks at today’s Plenary Session on risk-adapted screening for prostate cancer is the caution that